Residual risk and retrospective analysis of transfusion‐transmitted bacterial infection reported by the <scp>F</scp>rench <scp>N</scp>ational <scp>H</scp>emovigilance <scp>N</scp>etwork from 2000 to 2008

Abstract

The French hemovigilance system provides an accurate estimate of the TTBI incidence during a period with diversion and improving skin disinfection but without bacterial detection screening. This tool would be able to evaluate further additional safety procedures like bacterial screening and pathogen reduction technology.